Comparing the Antithrombotic Efficacy of a Humanized Anti-factor IX(a) Monoclonal Antibody (SB 249417) to the Low Molecular Weight Heparin Enoxaparin In a Rat Model of Arterial Thrombosis

By Toomey J.R.   Blackburn M.N.   Storer B.L.   Valocik R.E.   Koster P.F.   Feuerstein G.Z.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

MEASUREMENT OF ANTI-FACTOR IX IGG SUBCLASSES IN HAEMOPHILIA B PATIENTS WHO DEVELOPED INHIBITORS WITH EPISODES OF ALLERGIC REACTIONS TO FACTOR IX CONCENTRATES

By Sawamoto Y.   Shima M.   Yamamoto M.   Kamisue S.   Nakai H.   Tanaka I.   Hayashi K.   Giddings J.C.   Yoshioka A.  

Thrombosis Research, Vol. 83, Iss. 4, 1996-08 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite

Structure-Function Relationships in Factor IX and Factor IXa

By Schmidt A.E.   Bajaj S.P.  

Trends in Cardiovascular Medicine, Vol. 13, Iss. 1, 2003-01 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

Domain Specific Monoclonal Anti-factor VIII Antibodies Generated by Inclusion Body-renatured Factor VIII Peptides

By Huang C.-C.   Li L.-T.   Shen M.-C.   Chen  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 405-415

Elsevier

Access to resources Recommend Favorite

Localization of a metal-dependent epitope to the amino terminal residues 33-40 of human factor IX

By Wing-Fai C.   Wolberg A.S.   Stafford D.W.   Smith K.J.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 419-427

Elsevier

Access to resources Recommend Favorite